Survival in a randomised trial comparing two treatments for ovarian cancer
ovarian
futime: | survival or censoring time |
fustat: | censoring status |
age: | in years |
resid.ds: | residual disease present (1=no,2=yes) |
rx: | treatment group |
ecog.ps: | ECOG performance status (1 is better, see reference) |
Edmunson, J.H., Fleming, T.R., Decker, D.G., Malkasian, G.D., Jefferies, J.A., Webb, M.J., and Kvols, L.K., Different Chemotherapeutic Sensitivities and Host Factors Affecting Prognosis in Advanced Ovarian Carcinoma vs. Minimal Residual Disease. Cancer Treatment Reports, 63:241-47, 1979.